Science Explorer Back to mapMap

Most cited papers from Asklepios Klinik Altona

What are the most cited papers from Asklepios Klinik Altona?

The most cited paper from Asklepios Klinik Altona is "Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations" (J. Nygren, J. Thacker, F. Carli et al., 2012), with 2,179 citations. Next come "Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" (1,399) and "Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline" (1,118).

Showing 50 of 57 papers. Every paper with more than 145 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations J. Nygren, J. Thacker, F. Carli et al. · World Journal of Surgery Open access 5 Oct 2012 2,179
2 Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Guillem Argilés, Josep M. Tabernero, Roberto Labianca et al. · Annals of Oncology Open access 20 Jul 2020 1,399
3 Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline Monika Ferlitsch et al. · Endoscopy Open access 17 Feb 2017 1,118
4 Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations Ulf O Gustafsson, Michael J. Scott, W. Schwenk et al. · World Journal of Surgery Open access 5 Oct 2012 1,099
5 Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Arndt Vogel, Andrés Cervantes, Ian Chau et al. · Annals of Oncology Open access 30 Jul 2018 1,084
6 2018 update of the EULAR recommendations for the management of Behçet's syndrome Gülen Hatemi et al. · Annals of the Rheumatic Diseases Open access 6 Apr 2018 817
7 Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial Jesús F. San Miguel et al. · The Lancet Oncology 18 Sep 2014 796
8 International Perspectives on Emergency Department Crowding Jesse M. Pines et al. · Academic Emergency Medicine Dec 2011 667
9 Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage Joji B. Kuramatsu et al. · JAMA 24 Feb 2015 568
10 The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer David Cibula et al. · International Journal of Gynecological Cancer Open access 24 Apr 2018 486
11 Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer Salah‐Eddin Al‐Batran et al. · JAMA Oncology Open access 27 Apr 2017 485
12 ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023* David Cibula et al. · International Journal of Gynecological Cancer Open access May 2023 484
13 Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate Elisabeth Mangold et al. · Nature Genetics Open access 20 Dec 2009 443
14 Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project Mattia D’Agostino et al. · Journal of Clinical Oncology Open access 23 May 2022 430
15 Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial Shaji Kunnathu Kumar, Simon James Harrison, Michèle Cavo et al. · The Lancet Oncology 30 Oct 2020 412
16 Capsule Endoscopy versus Colonoscopy for the Detection of Polyps and Cancer A. Van Gossum et al. · New England Journal of Medicine Open access 15 Jul 2009 370
17 Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci Kerstin U. Ludwig et al. · Nature Genetics Open access 3 Aug 2012 364
18 Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p Kai Neben et al. · Blood 8 Dec 2011 357
19 Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study Klaus‐Peter Dieckmann et al. · Journal of Clinical Oncology Open access 15 Mar 2019 354
20 Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study Arvind N. Dasari et al. · The Lancet Open access 16 Jun 2023 351
21 ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up Friedemann U. Honecker et al. · Annals of Oncology Open access 18 Jun 2018 331
22 Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates Hans van der Ven, Jana Liebenthron, Matthias W. Beckmann et al. · Human Reproduction 4 Jul 2016 313
23 Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study Jan Menne et al. · BMJ Open access 19 Jul 2012 310
24 Polyetheretherketone—cytotoxicity and mutagenicity in vitro Alexander Katzer, Hans W.J. Marquardt, Johannes Westendorf et al. · Biomaterials Apr 2002 296
25 Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline C. Spada et al. · Endoscopy Open access 2 Mar 2012 292
26 Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD Richard F. Schlenk et al. · Blood Open access 18 Dec 2018 290
27 Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS Kei Muro et al. · Annals of Oncology Open access 13 Nov 2018 290
28 Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction William T. Abraham, Michael R. Zile, Fred A. Weaver et al. · JACC Heart Failure Open access 13 May 2015 284
29 Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Sheela Rao, Marianne G. Guren, Khurum Hayat Khan et al. · Annals of Oncology Open access 24 Jun 2021 265
30 Functional Outcome Following Stroke Thrombectomy in Clinical Practice Frank Arne Wollenweber et al. · Stroke Open access 24 Jul 2019 255
31 A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study Ö. Türeci, Uğur Şahin, Henning Schulze‐Bergkamen et al. · Annals of Oncology Open access 25 Jun 2019 251
32 Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer Hedy Lee Kindler, Pascal Hammel, Michele Reni et al. · Journal of Clinical Oncology Open access 14 Jul 2022 241
33 Final results of the EORTC 18871/DKG 80-1 randomised phase III trial Ulrich Richard Kleeberg, Stefan Suciu, E.‐B. Bröcker et al. · European Journal of Cancer 4 Dec 2003 240
34 Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial Jens Huober, Peter Andreas Fasching, Maged Sami Barsoum et al. · The Breast Open access 9 Sep 2011 228
35 Melanoma and use of sunscreens: An EORTC case‐control study in germany, belgium and france Philippe Autier, Jean‐François Doré, Eugène Schifflers et al. · International Journal of Cancer 9 Jun 1995 225
36 Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS Kei Muro et al. · Annals of Oncology Open access 13 Nov 2018 224
37 A novel lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic fluid collections: a prospective cohort study Daisy Walter, Uwe Will, Andrés Sánchez-Yagüe et al. · Endoscopy Open access 30 Sep 2014 218
38 Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study Shubham Pant et al. · The Lancet Oncology Open access133 authors Aug 2023 216
39 EUS-guided drainage of pancreatic fluid collections using a novel lumen-apposing metal stent on an electrocautery-enhanced delivery system: a large retrospective study (with video) Emanuele Rinninella, Rastislav Kunda, Markus Dollhopf et al. · Gastrointestinal Endoscopy Open access 23 May 2015 207
40 Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial Hartmut Goldschmidt et al. · Leukemia Open access 4 Jul 2017 204
41 Schlaganfallhäufigkeit und Versorgung von Schlaganfallpatienten in Deutschland Peter Heuschmann, O. Busse, Mandy Wagner et al. · Aktuelle Neurologie Sep 2010 199
42 German Mobile Apps in Rheumatology: Review and Analysis Using the Mobile Application Rating Scale (MARS) Johannes Knitza, Koray Taşçılar, Eva-Maria Meßner et al. · JMIR mhealth and uhealth Open access 19 Jul 2019 198
43 Laparoscopic radical hysterectomy with transvaginal closure of vaginal cuff – a multicenter analysis Christhardt Köhler, Hermann Hertel, Jörg Herrmann et al. · International Journal of Gynecological Cancer Open access Jun 2019 195
44 Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study Muriel Elhaï et al. · Annals of the Rheumatic Diseases Open access 9 Apr 2019 192
45 Prognostic factors in medullary thyroid carcinomas.Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content Sören Schröder, W. Böcker, Heinz Baisch et al. · Cancer Open access 15 Feb 1988 192
46 Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Ralf‐Dieter Hofheinz, E Fokas, Léonor Benhaïm et al. · Annals of Oncology Open access 22 May 2025 191
47 Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage Joji B. Kuramatsu et al. · JAMA Open access 8 Oct 2019 186
48 Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry for the Study Alliance Leukemia (SAL) et al. · Journal of Hematology & Oncology Open access 4 Mar 2016 185
49 EUS-guided choledochoduodenostomy for malignant distal biliary obstruction using a lumen-apposing fully covered metal stent after failed ERCP Rastislav Kunda, Manuel Pérez‐Miranda, Uwe Will et al. · Surgical Endoscopy 11 Mar 2016 184
50 Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban Thorsten Steiner, Michael C Böhm, Martin Dichgans et al. · Clinical Research in Cardiology 13 May 2013 183

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.